About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Odiparcil QT Definitive Study

NCT00437242·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

18–60

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Inclusion:
Healthy volunteers
Exclusion:
Cardiac abnormalities
Hepatic or renal insufficiency
Anti-coagulant medications
Bleeding history

The record

StatusTerminated

PhasePhase 1

Taking part54

StartedOct 2006

UpdatedJun 4, 2012

Conditions

Fibrillation, Atrial Atrial Fibrillation

Where1

GSK Investigational Site
Austin, Texas, United States

Clareo Health | Odiparcil QT Definitive Study